WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)

WITHUS PHARMACEUTICAL Co.,LTD. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020
Cash & Equivalents	7,654	9,173	9,012	13,831	15,490	25,146
Short-Term Investments	1,000	1,000	10,500	2,500	3,500	2,500
Trading Asset Securities	-	1,019	7,044	26,147	20,444	17,028
Cash & Short-Term Investments	8,654	11,192	26,556	42,478	39,435	44,674
Cash Growth	-51.17%	-57.85%	-37.48%	7.72%	-11.73%	56.07%
Accounts Receivable	27,180	25,797	17,835	18,635	20,408	20,502
Other Receivables	32.51	292.43	77.42	78.45	81.57	80.89
Receivables	31,348	30,978	23,372	24,228	26,625	21,844
Inventory	17,028	16,004	9,021	8,141	7,922	6,974
Prepaid Expenses	60.34	43.49	317.7	1,523	26.92	26.55
Other Current Assets	173.7	29.52	183.79	58.6	6.28	10.78
Total Current Assets	57,264	58,247	59,451	76,427	74,015	73,530
Property, Plant & Equipment	49,887	49,945	39,843	25,379	20,071	19,383
Long-Term Investments	11,261	12,099	9,637	8,733	7,209	5,756
Other Intangible Assets	3,984	2,532	2,528	1,548	1,542	1,543
Long-Term Accounts Receivable	-0	-0	0	-0	0	-
Long-Term Deferred Tax Assets	1,382	1,198	1,549	1,380	1,459	1,268
Long-Term Deferred Charges	6,614	6,315	5,893	5,035	1,408	431.9
Other Long-Term Assets	88.07	443.21	493.87	476.13	475.93	733.82
Total Assets	130,479	130,780	119,395	118,979	106,180	107,013
Accounts Payable	3,923	7,190	3,447	2,435	2,869	2,891
Accrued Expenses	1,143	1,066	1,037	1,154	1,085	1,094
Short-Term Debt	15,185	11,424	12,519	12,839	10,589	11,396
Current Portion of Long-Term Debt	2,333	3,333	2,000	1,000	1,900	1,900
Current Portion of Leases	179.74	201.49	172.31	280.27	303.09	248.27
Current Income Taxes Payable	443.1	243.82	645.94	761.3	128.5	933.92
Other Current Liabilities	8,601	7,552	5,752	5,506	3,475	5,697
Total Current Liabilities	31,808	31,011	25,572	23,975	20,349	24,161
Long-Term Debt	3,500	4,667	6,600	8,700	4,000	1,600
Long-Term Leases	285.38	375.14	175.65	285.61	426.53	370.35
Other Long-Term Liabilities	-	0	0	-	0	-0
Total Liabilities	39,758	40,502	36,359	38,074	29,303	30,253
Common Stock	2,640	2,640	2,639	2,638	1,758	1,758
Additional Paid-In Capital	15,109	15,109	14,997	14,948	15,846	15,846
Retained Earnings	72,337	71,894	64,736	62,642	58,880	58,941
Treasury Stock	-35.66	-35.66	-35.66	-35.66	-	-
Comprensive Income & Other	670.63	670.63	700.16	713.26	393.34	214.54
Shareholders' Equity	90,721	90,278	83,036	80,905	76,877	76,759
Total Liabilities & Equity	130,479	130,780	119,395	118,979	106,180	107,013
Total Debt	21,483	20,001	21,467	23,105	17,219	15,514
Net Cash (Debt)	-12,829	-8,809	5,089	19,373	22,216	29,159
Net Cash Growth	-	-	-73.73%	-12.80%	-23.81%	67.61%
Net Cash Per Share	-971.56	-667.81	385.93	1467.59	2685.10	3757.98
Filing Date Shares Outstanding	13.2	13.2	13.19	13.19	13.19	7.77
Total Common Shares Outstanding	13.2	13.2	13.19	13.19	13.19	7.77
Working Capital	25,456	27,236	33,878	52,452	53,666	49,369
Book Value Per Share	6872.96	6839.41	6295.23	6135.62	5829.05	9878.73
Tangible Book Value	86,737	87,746	80,508	79,357	75,335	75,217
Tangible Book Value Per Share	6571.12	6647.62	6103.58	6018.20	5712.10	9680.17
Land	6,985	6,985	6,596	6,238	6,238	5,916
Buildings	34,896	34,896	10,057	9,657	9,657	9,350
Machinery	19,583	18,050	14,250	13,519	12,346	11,673
Construction In Progress	1,649	1,976	19,751	5,838	546	533.02

Source: S&P Capital IQ. Standard template. Financial Sources.